Skip to main content
Clinical Trials/ChiCTR2000033405
ChiCTR2000033405Not yet recruitingEarly Phase 1

基于房水多肽组学的糖尿病视网膜病变分期辨证研究

政府课题资助或自筹经费1 site in 1 countryStarted: January 1, 2021Last updated:
Conditions

Trial Snapshot

Phase
Early Phase 1
Status
Not yet recruiting
Sponsor
Locations
1
Primary Endpoint
房水多肽组学

Study Overview

Brief Summary

本研究的目的本研究拟通过 LC-MS/MS 对手术患者房水进行多肽组学检测,找到不同分期不同证型糖尿病视网膜病变患者的差异多肽,并建立稳定的诊断模型。

Study Design

Study Type
诊断试验
Primary Purpose
析因分组(即根据危险因素或暴露因素分组)
Masking
未说明

Eligibility Criteria

Ages
40 to 90 (—)
Sex
All

Inclusion Criteria

  • 医院眼科的手术患者,主要包括白内障手术和糖尿病视网膜病变手术。

Exclusion Criteria

  • 恶性肿瘤及自身免疫性疾病等;继发性糖尿病及妊娠期糖尿病、高血压视网膜病变、虹膜及睫状体病变、青光眼患者。

Outcomes

Primary Outcomes

房水多肽组学

SEN, SPE, ACC, AUC of ROC

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
政府课题资助或自筹经费

Study Sites (1)

Loading locations...

Similar Trials